FRANKLIN RESOURCES INC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 56 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2018$524,000
-63.1%
110,400
-54.6%
0.00%
-100.0%
Q4 2017$1,419,000
+177.7%
243,4000.0%0.00%
Q3 2017$511,000
-55.1%
243,4000.0%0.00%
-100.0%
Q2 2017$1,139,000
-40.1%
243,4000.0%0.00%0.0%
Q1 2017$1,903,000
-51.9%
243,400
-24.5%
0.00%
-50.0%
Q4 2016$3,953,000
-59.4%
322,400
-48.4%
0.00%
-60.0%
Q3 2016$9,744,000
+28.5%
625,0000.0%0.01%
+25.0%
Q2 2016$7,581,000625,0000.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2016
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 440,627$2,093,0002.25%
NEA Management Company, LLC 5,556,778$26,395,0001.17%
Endurant Capital Management LP 472,012$2,242,0000.84%
DAFNA Capital Management LLC 267,100$1,269,0000.62%
RTW INVESTMENTS, LP 1,104,940$5,248,0000.50%
DOHENY ASSET MANAGEMENT /CA 69,625$331,0000.17%
BAILARD, INC. 520,100$2,470,0000.16%
Bain Capital Public Equity Management, LLC 399,947$1,900,0000.14%
Rock Springs Capital Management LP 675,000$3,206,0000.14%
Hillhouse Capital Management 865,923$4,113,0000.07%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders